Intratumoral chemotherapy is an innovative non-small cell lung cancer treatment we are pioneering at Cancer Treatment Centers of America (CTCA) at Southwestern Regional Medical Center (Southwestern).
The study explores the effectiveness of Cisplatin (a chemotherapy drug), when injected directly into a lung tumor followed by HDR brachytherapy. The goal is to improve the quality of life for lung cancer patients with airway blockage problems.
In 2011, Southwestern began offering intratumoral chemotherapy as an adjuvant treatment for pancreatic cancer patients.
Using endoscopic ultrasound (EUS) we can inject chemotherapy directly into the pancreatic tumor. The goal is to shrink the tumor, reduce pain and prevent recurrence.
The procedure is done once a week for four weeks with a CT scan completed before the first treatment and after the final one to gauge results.